Literature DB >> 15914464

Multiple signaling states of G-protein-coupled receptors.

Dianne M Perez1, Sadashiva S Karnik.   

Abstract

Studies have been amassed in the past several years indicating that an agonist can conform a receptor into an activation state that is dependent upon an intrinsic property of the agonist usually based upon its chemical composition. Theoretically, each different agonist could impart its own unique activation state. Evidence for multiple signaling states for the G-protein-coupled receptors will be reviewed and is derived from many different pharmacological behaviors: efficacy, kinetics, protean agonism, differential desensitization and internalization, inverse agonism, and fusion chimeras. A recent extension of the ternary complex model is suggested by evidence that the different processes that govern deactivation, such as desensitization and internalization, is also regulated by conformers specific to the agonist. Rhodopsin may serve as a primer for the study of multiple activation states. Therapeutic implications that utilize multiple signaling states hold vast promise in the rationale design of drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15914464     DOI: 10.1124/pr.57.2.2

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  73 in total

1.  ET-1 induced Elevation of intracellular calcium in clonal neuronal and embryonic kidney cells involves endogenous endothelin-A receptors linked to phospholipase C through Gα(q/11).

Authors:  Jean-Pierre Montmayeur; Travis P Barr; Sarah A Kam; Samuel J Packer; Gary R Strichartz
Journal:  Pharmacol Res       Date:  2011-04-14       Impact factor: 7.658

Review 2.  Biased signalling and allosteric machines: new vistas and challenges for drug discovery.

Authors:  Terry P Kenakin
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 3.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 4.  Ensemble of G protein-coupled receptor active states.

Authors:  P S-H Park
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

5.  In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?

Authors:  B B Yao; S Mukherjee; Y Fan; T R Garrison; A V Daza; G K Grayson; B A Hooker; M J Dart; J P Sullivan; M D Meyer
Journal:  Br J Pharmacol       Date:  2006-08-07       Impact factor: 8.739

6.  Asymmetric conformational changes in a GPCR dimer controlled by G-proteins.

Authors:  Marjorie Damian; Aimée Martin; Danielle Mesnier; Jean-Philippe Pin; Jean-Louis Banères
Journal:  EMBO J       Date:  2006-11-30       Impact factor: 11.598

7.  The receptor concept: pharmacology's big idea.

Authors:  H P Rang
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

8.  BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes.

Authors:  Yvan Dumont; Pierrette Gaudreau; Manuela Mazzuferi; Daniel Langlois; Jean-Guy Chabot; Alain Fournier; Michele Simonato; Rémi Quirion
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

Review 9.  Biased signaling at neural melanocortin receptors in regulation of energy homeostasis.

Authors:  Li-Kun Yang; Ya-Xiong Tao
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-04-19       Impact factor: 5.187

10.  The Gq and G12 families of heterotrimeric G proteins report functional selectivity.

Authors:  Li Zhang; Lawrence F Brass; David R Manning
Journal:  Mol Pharmacol       Date:  2008-10-24       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.